UNITED THERAPEUTICS

Serial Number 75403424
606

Registration Progress

Application Filed
Dec 5, 1997
Under Examination
Dec 21, 1999
Approved for Publication
Aug 27, 1999
Published for Opposition
Sep 28, 1999
Registered

Basic Information

Serial Number
75403424
Filing Date
December 5, 1997
Published for Opposition
September 28, 1999
Abandonment Date
December 22, 2000
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 22, 2000
Classes
005 042

Rights Holder

UNITED THERAPEUTICS CORPORATION

03
Address
68 TW ALEXANDER DRIVE
RESEARCH TRIANGLE PARK, NC 27709

Ownership History

LRX Pharmaceuticals, Inc.

Original Applicant
03
Washington, D.C., DC

UNITED THERAPEUTICS CORPORATION

New Owner Before Publication #1
03
RESEARCH TRIANGLE PARK, NC

UNITED THERAPEUTICS CORPORATION

Owner at Publication
03
RESEARCH TRIANGLE PARK, NC

Legal Representation

Attorney
PAUL A MAHON

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description
May 8, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Aug 4, 2000 DPCC D DIVISIONAL PROCESSING COMPLETE
Aug 2, 2000 EX1G S SOU EXTENSION 1 GRANTED
Jun 13, 2000 EXT1 S SOU EXTENSION 1 FILED
Jan 21, 2000 DRRR I DIVISIONAL REQUEST RECEIVED
Dec 21, 1999 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 28, 1999 PUBO A PUBLISHED FOR OPPOSITION
Aug 27, 1999 NPUB O NOTICE OF PUBLICATION
Jun 19, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 20, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 1999 CNSL F LETTER OF SUSPENSION MAILED
Mar 8, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 1998 CNSL F LETTER OF SUSPENSION MAILED
Sep 4, 1998 CNEA F EXAMINER'S AMENDMENT MAILED
Aug 10, 1998 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of chronic conditions, namely, chronic liver disease, chronic central nervous system disease, chronic gastroenterological disease, metastatic cancer and chronic respiratory disease
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
medical services, namely, development and implementation of medical therapies for different chronic conditions and diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"